237 related articles for article (PubMed ID: 24699257)
1. Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
Wei F; Liu J; Liu F; Hu H; Ren H; Hu P
PLoS One; 2014; 9(4):e90611. PubMed ID: 24699257
[TBL] [Abstract][Full Text] [Related]
2. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.
Wang CS; Ko HH; Yoshida EM; Marra CA; Richardson K
Am J Transplant; 2006 Jul; 6(7):1586-99. PubMed ID: 16827859
[TBL] [Abstract][Full Text] [Related]
3. Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients.
Devaki P; Jencks D; Yee BE; Nguyen MH
Hepatol Int; 2015 Jul; 9(3):431-7. PubMed ID: 26016464
[TBL] [Abstract][Full Text] [Related]
4. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
Xirouchakis E; Triantos C; Manousou P; Sigalas A; Calvaruso V; Corbani A; Leandro G; Patch D; Burroughs A
J Viral Hepat; 2008 Oct; 15(10):699-709. PubMed ID: 18673428
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.
Fabrizi F; Lunghi G; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Nov; 24(10):1413-22. PubMed ID: 17081162
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.
Fabrizi F; Penatti A; Messa P; Martin P
J Med Virol; 2014 Jun; 86(6):933-40. PubMed ID: 24610278
[TBL] [Abstract][Full Text] [Related]
7. Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.
Yamada G; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
Clin Drug Investig; 2008; 28(1):9-16. PubMed ID: 18081356
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy.
Singal AG; Waljee AK; Shiffman M; Bacon BR; Schoenfeld PS
Aliment Pharmacol Ther; 2010 Oct; 32(8):969-83. PubMed ID: 20937042
[TBL] [Abstract][Full Text] [Related]
9. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
Gordon CE; Uhlig K; Lau J; Schmid CH; Levey AS; Wong JB
Am J Kidney Dis; 2008 Feb; 51(2):263-77. PubMed ID: 18215704
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495
[TBL] [Abstract][Full Text] [Related]
11. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
Prabhu RA; Nair S; Pai G; Reddy NP; Suvarna D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007003. PubMed ID: 26287983
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for acute hepatitis C infection.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
[TBL] [Abstract][Full Text] [Related]
13. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
15. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.
Gurusamy KS; Tsochatzis E; Toon CD; Xirouchakis E; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006803. PubMed ID: 24307460
[TBL] [Abstract][Full Text] [Related]
16. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
[TBL] [Abstract][Full Text] [Related]
17. Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.
Laguno M; Von Wichmann MA; Van den Eynde E; Navarro J; Cifuentes C; Murillas J; Veloso S; Martínez-Rebollar M; Guardiola JM; Jou A; Gómez-Sirvent JL; Cervantes M; Pineda JA; López-Calvo S; Carrero A; Montes ML; Deig E; Tapiz A; Ruiz-Mesa JD; Cruceta A; de Lazzari E; Mallolas J
Int J Infect Dis; 2016 Dec; 53():46-51. PubMed ID: 27815225
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients.
Aljumah AA; Saeed MA; Al Flaiw AI; Al Traif IH; Al Alwan AM; Al Qurashi SH; Al Ghamdi GA; Al Hejaili FF; Al Balwi MA; Al Sayyari AA
World J Gastroenterol; 2012 Jan; 18(1):55-63. PubMed ID: 22228971
[TBL] [Abstract][Full Text] [Related]
19. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
Wang X; Liu F; Wei F; Ren H; Hu H
PLoS One; 2014; 9(6):e100128. PubMed ID: 24963667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
